1 E: [email protected] W: www.claritypharmaceuticals.com ACN: 143 005 341 T: +61 (0)2 9209 4037 CLARITY PHARMACEUTICALS LIMITED A S X A N N O U N C E M E N T 21 September 2026 Date of Annual General Meeting – 25 November 2026 Clarity Pharmaceuticals (ASX: CU6)...
Date of Annual General Meeting 25 November 2026
Filed with ASX · · 1 page · English
Summary by 6ix AI
The announcement complies with Listing Rule requirements and includes details about the closing date for director nominations. Further information regarding the AGM will be provided in a separate Notice of Meeting to be sent to shareholders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Clarity Pharmaceuticals Ltd. on 6ix
Story so far
Earlier from Clarity Pharmaceuticals
- Preliminary Final Report
- Becoming a substantial holder
- Ceasing to be a substantial holder
- Bioshares Biotech Summit Presentation
- Clarity Pharmaceuticals Announces SECuRE Trial Update on 8 GBq 67Cu-SAR-bisPSMA dose level with two additional complete responses
Later from Clarity Pharmaceuticals
- Annual Report to shareholders
- Appendix 4G
- Corporate governance statement
- SECuRE update
- SAR-bisPSMA Presentation - Drug & Device Conference
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals